Endocrinology Section, Department of Clinical and Experimental Medicine, Garibaldi Nesima Hospital, University of Catania, Catania, Italy.
Servizio di Endocrinologia e Diabetologia, Ospedale Regionale di Lugano, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.
Eur Thyroid J. 2024 Mar 15;13(2). doi: 10.1530/ETJ-23-0242. Print 2024 Apr 1.
Ultrasound-based risk stratification systems (Thyroid Imaging Reporting and Data Systems (TIRADSs)) of thyroid nodules (TNs) have been implemented in clinical practice worldwide based on their high performance. However, it remains unexplored whether different TIRADSs perform uniformly across a range of TNs in routine practice. This issue is highly relevant today, given the ongoing international effort to establish a unified TIRADS (i.e. I-TIRADS), supported by the leading societies specializing in TNs. The study aimed to conduct a direct comparison among ACR-, EU-, and K-TIRADS in the distribution of TNs: (1) across the TIRADS categories, and (2) based on their estimated cancer risk.
A search was conducted on PubMed and Embase until June 2023. Original studies that sequentially assessed TNs using TIRADSs, regardless of FNAC indication, were selected. General study characteristics and data on the distribution of TNs across TIRADSs were extracted.
Seven studies, reporting a total of 41,332 TNs, were included in the analysis. The prevalence of ACR-TIRADS 1-2 was significantly higher than that of EU-TIRADS 2 and K-TIRADS 2, with no significant difference observed among intermediate- and high-risk categories of TIRADSs. According to malignancy risk estimation, K-TIRADS often classified TNs as having more severe risk, ACR-TIRADS as having moderate risk, and EU-TIRADS classified TNs as having lower risk.
ACR-, EU-, and K-TIRADS assess TNs similarly across their categories, with slight differences in low-risk classifications. Despite this, focusing on cancer risk estimation, the three TIRADSs assess TNs differently. These findings should be considered as a prerequisite for developing the I-TIRADS.
基于其优异的性能,甲状腺结节(TNs)的超声风险分层系统(甲状腺影像报告和数据系统(TIRADSs))已在全球临床实践中得到应用。然而,在常规实践中,不同的 TIRADS 在一系列 TNs 中的表现是否一致,这一问题仍未得到探索。鉴于各专业协会支持的建立统一 TIRADS(即 I-TIRADS)的国际努力仍在进行,这一问题在今天显得尤为重要。本研究旨在对 ACR、EU 和 K-TIRADS 在 TN 分布方面进行直接比较:(1)在 TIRADS 类别之间,以及(2)基于其估计的癌症风险。
对 PubMed 和 Embase 进行了检索,检索截至 2023 年 6 月。选择了使用 TIRADSs 对 TNs 进行连续评估的原始研究,无论 FNAC 指征如何。提取了一般研究特征和 TNs 在 TIRADS 中的分布数据。
纳入分析的共有 7 项研究,共报告了 41332 个 TN。ACR-TIRADS 1-2 的患病率显著高于 EU-TIRADS 2 和 K-TIRADS 2,而 TIRADS 中间和高危类别之间无显著差异。根据恶性肿瘤风险估计,K-TIRADS 通常将 TNs 归类为风险较高,ACR-TIRADS 归类为风险中等,而 EU-TIRADS 将 TNs 归类为风险较低。
ACR、EU 和 K-TIRADS 在其类别中对 TNs 进行了相似的评估,在低风险分类方面存在细微差异。尽管如此,基于癌症风险估计,这三种 TIRADSs 对 TNs 的评估方式不同。这些发现应被视为制定 I-TIRADS 的前提条件。